Stefan Rieken

6.4k total citations
210 papers, 4.3k citations indexed

About

Stefan Rieken is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Stefan Rieken has authored 210 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 77 papers in Oncology and 60 papers in Genetics. Recurrent topics in Stefan Rieken's work include Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (41 papers) and Advanced Radiotherapy Techniques (36 papers). Stefan Rieken is often cited by papers focused on Glioma Diagnosis and Treatment (59 papers), Brain Metastases and Treatment (41 papers) and Advanced Radiotherapy Techniques (36 papers). Stefan Rieken collaborates with scholars based in Germany, United States and Switzerland. Stefan Rieken's co-authors include Jürgen Debus, Stephanie E. Combs, Daniel Habermehl, Sebastian Adeberg, Thomas Welzel, Denise Bernhardt, Klaus Herfarth, Thomas Haberer, Oliver Jäkel and Harald Rief and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Stefan Rieken

201 papers receiving 4.2k citations

Peers

Countries citing papers authored by Stefan Rieken

Since Specialization

Citations

This map shows the geographic impact of Stefan Rieken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Rieken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Rieken more than expected).

Fields of papers citing papers by Stefan Rieken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Rieken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Rieken. The network helps show where Stefan Rieken may publish in the future.

Co-authorship network of co-authors of Stefan Rieken

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Rieken. A scholar is included among the top collaborators of Stefan Rieken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Rieken. Stefan Rieken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trachealtumoren 2025 ·Laryngo-Rhino-Otologie ·Florian Eichhorn, Hans Hoffmann, Stefan Rieken, Felix Herth, H. Winter	0
2	Efficacy and safety of immune checkpoint inhibition combined with concurrent chemoradiotherapy in patients with stage III unresectable non-small cell lung cancer: A systematic review and meta-analysis 2025 ·European Journal of Cancer ·(unknown), Martin Reck, Daniel Martín, Stefan Rieken, (unknown), (unknown), (unknown), (unknown), Hubert Serve, Thomas Oellerich, Martin Sebastian, Friederike C. Althoff	3
3	DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma 2022 ·Acta Neuropathologica ·Sebastian Adeberg, Maximilian Knoll, Christian Koelsche, Denise Bernhardt, Daniel Schrimpf, Felix Sahm, Laila König, Semi Harrabi, Juliane Hörner‐Rieber, Vivek Verma, Melanie Bewerunge‐Hudler, Andreas Unterberg, Dominik Sturm, Christine Jungk, Christel Herold‐Mende, Wolfgang Wick, Andreas von Deimling, Jürgen Debus, Stefan Rieken, Amir Abdollahi	7
4	Whole Blood Transcriptional Fingerprints of High-Grade Glioma and Longitudinal Tumor Evolution under Carbon Ion Radiotherapy 2022 ·Cancers ·Maximilian Knoll, (unknown), Jennifer Furkel, Ute Wirkner, Aoife Ward, Ivana Đokić, Christian Schwager, Sebastian Adeberg, Stefan Rieken, Tobias Keßler, Felix Sahm, Laila König, Christel Herold‐Mende, Stephanie E. Combs, Jürgen Debus, Amir Abdollahi	5
5	Neurocognitive Outcomes in Pediatric Patients Following Brain Irradiation 2021 ·Cancers ·(unknown), (unknown), Sebastian Regnery, Laila König, Denise Bernhardt, Olaf Witt, Klaus Herfarth, Andreas Unterberg, Christine Jungk, (unknown), Stephanie E. Combs, Jürgen Debus, Stefan Rieken, Semi Harrabi, Sebastian Adeberg	18
6	Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma 2020 ·Radiotherapy and Oncology ·Paul Windisch, Manuel Röhrich, Sebastian Regnery, Eric Tonndorf‐Martini, Thomas Held, Kristin Lang, Denise Bernhardt, Stefan Rieken, Frederik L. Giesel, Uwe Haberkorn, Jürgen Debus, Sebastian Adeberg	53
7	<p>Percutaneous Endoscopic Gastrostomy Tube Placement in Patients with Head and Neck Cancer Treated with Radiotherapy</p> 2020 ·Cancer Management and Research ·Kristin Lang, Rami A. El Shafie, Sati Akbaba, Ronald Koschny, Nina Bougatf, Denise Bernhardt, Stefan Welte, Sebastian Adeberg, Matthias Häfner, Steffen Kargus, Peter K. Plinkert, Jürgen Debus, Stefan Rieken	12
8	Pre-Operative Versus Post-Operative Radiosurgery of Brain Metastases—Volumetric and Dosimetric Impact of Treatment Sequence and Margin Concept 2019 ·Cancers ·Rami A. El Shafie, Eric Tonndorf‐Martini, Daniela Schmitt, Dorothea Weber, (unknown), (unknown), Denise Bernhardt, Kristin Lang, Philipp Hoegen, Sebastian Adeberg, Angela Paul, Jürgen Debus, Stefan Rieken	19
9	Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control 2019 ·Cancers ·Sati Akbaba, Thomas Held, Kristin Lang, Tobias Förster, P. Federspil, Klaus Herfarth, Matthias Häfner, Peter K. Plinkert, Stefan Rieken, Jürgen Debus, Sebastian Adeberg	15
10	Dose-Limiting Organs at Risk in Carbon Ion Re-Irradiation of Head and Neck Malignancies: An Individual Risk-Benefit Tradeoff 2019 ·Cancers ·Thomas Held, Semi Harrabi, Kristin Lang, Sati Akbaba, Paul Windisch, Denise Bernhardt, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	6
11	The impact of age on the outcome of patients treated with radiotherapy for mucoepidermoid carcinoma (MEC) of the salivary glands in the head and neck: A 15-year single-center experience 2019 ·Oral Oncology ·Sati Akbaba, (unknown), Andreas Möck, Thomas Held, Kristin Lang, (unknown), Tobias Förster, Sonja Katayama, Steffen Kargus, Stefan Rieken, Peter K. Plinkert, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	8
12	Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions 2019 ·Radiation Oncology ·Thomas Held, Paul Windisch, Sati Akbaba, Kristin Lang, (unknown), Jakob Liermann, Denise Bernhardt, Peter K. Plinkert, Christian Freudlsperger, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	5
13	Clinical Management of Blood–Brain Barrier Disruptions after Active Raster-Scanned Carbon Ion Re-Radiotherapy in Patients with Recurrent Head-and-Neck Cancer 2019 ·Cancers ·Thomas Held, Sati Akbaba, Kristin Lang, Semi Harrabi, Denise Bernhardt, Christian Freudlsperger, Steffen Kargus, Peter K. Plinkert, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	7
14	Oncogene addiction and radiation oncology: effect of radiotherapy with photons and carbon ions in ALK-EML4 translocated NSCLC 2018 ·Radiation Oncology ·Ying Dai, (unknown), Christian Schwager, Janina Hanne, Cheng Zhou, Klaus Herfarth, Stefan Rieken, Kenneth E. Lipson, Jürgen Debus, Amir Abdollahi	41
15	Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy 2018 ·Scientific Reports ·(unknown), (unknown), Ralf Floca, Ali Afshar‐Oromieh, Nina Bougatf, Sebastian Adeberg, Sabine Heiland, Martin Bendszus, Wolfgang Wick, Stefan Rieken, Uwe Haberkorn, Jürgen Debus, Maximilian Knoll, Amir Abdollahi	31
16	Intensity Modulated Radiotherapy (IMRT) + Carbon Ion Boost for Adenoid Cystic Carcinoma of the Minor Salivary Glands in the Oral Cavity 2018 ·Cancers ·Kristin Lang, (unknown), Sati Akbaba, Thomas Held, Steffen Kargus, Nina Bougatf, Denise Bernhardt, Kolja Freier, Peter K. Plinkert, Stefan Rieken, Jürgen Debus, Sebastian Adeberg	15
17	Accelerated Hypofractionated Active Raster-Scanned Carbon Ion Radiotherapy (CIRT) for Laryngeal Malignancies: Feasibility and Safety 2018 ·Cancers ·Sati Akbaba, Kristin Lang, Thomas Held, Olcay Cem Bulut, (unknown), Matthias Uhl, Alexandra D Jensen, Peter K. Plinkert, Stefan Rieken, Klaus Herfarth, Jürgen Debus, Sebastian Adeberg	9
18	EML4‐ALK fusion variant V3 is a high‐risk feature conferring accelerated metastatic spread, early treatment failure and worse overall survival in ALK⁺ non‐small cell lung cancer 2018 ·International Journal of Cancer ·Petros Christopoulos, Volker Endris, Farastuk Bozorgmehr, (unknown), Martina Kirchner, Jonas Ristau, Ivo Buchhalter, Roland Penzel, Felix Herth, Claus Peter Heußel, Martin Eichhorn, Thomas Muley, Michael Meister, Jürgen R. Fischer, Stefan Rieken, Arne Warth, Helge Bischoff, Peter Schirmacher, Albrecht Stenzinger, Michael Thomas	79
19	Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location 2018 ·Cancers ·Sebastian Adeberg, Semi Harrabi, Nina Bougatf, Vivek Verma, Paul Windisch, Denise Bernhardt, Stephanie E. Combs, Klaus Herfarth, Jürgen Debus, Stefan Rieken	43
20	Treatment of meningioma and glioma with protons and carbon ions 2017 ·Radiation Oncology ·Sebastian Adeberg, Semi Harrabi, Vivek Verma, Denise Bernhardt, (unknown), Jürgen Debus, Stefan Rieken	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact